A Study Of The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors.
Clinical trial NCT04341259 · COMPLETED
Trial details
- NCT number
- NCT04341259
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-03
- Primary completion
- 2023-04-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.